FindTrial
Sign In

To compare effectiveness between sthaulyahar kashay ghana vati and tab rosuvastatin in the management of medovruddhi in sthaulya with special reference to hyperlipidemia

A Randomized Controlled Clinical Trial To evaluate the efficacy between sthaulyahar kashay ghana vati and tab rosuvastatin in the management of medovruddhi in sthaulya with special reference to hyperlipidemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078930
Enrollment
80
Registered
2025-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E66- Overweight and obesity

Interventions

None listed

Sponsors

PDEAs college of ayurveda and research centre , Nigadi Pradhikaran , Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A) BMI : 25.0 - 39.9 kg/m2 B) SR CHOLESTEROL : ABOVE 200 mg/dl TO 350 mg/dl OR SR TRIGLYCERIDE : ABOVE 150 mg/dl TO 300 mg/dl OR SR LDL : ABOVE 150 mg/dl to 250 mg/dl C)patient having 2 or more symptoms 1 Ati sthaulya (excess hunger)2 Ati trushna (excessthirst)3 Ati swed (excess sweating)4 Ati shwas (breathlessness)5 Ati nidrata (excess sleep)6 ays akshamata (fatigue) above symptoms are from ashtang sangraha

Exclusion criteria

Exclusion criteria: K/C/O 1 renal impairement, IHD, TB, AIDS, CA, cerebral diseases, hepatitis, hypothyroidism 2 uncontrolled DM (HbA1C above 9 %) 3 autoimmune diseases and taking steroid therapy 4 pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
to get reduced BMI, reduced trigyceride and cholesterol value,reduced symptoms of obesity as mentioned earlier Timepoint: 12 weeks follow up of 4 weeks—

Secondary

MeasureTime frame
to observe adverse effect,if anyTimepoint: 12 weeks follow up of 4 weeks—

Countries

India

Contacts

Public ContactDR Mandar Pramod Garud

PDEAs college of ayurveda and research centre , Nigadi Pradhikaran , Pune

vrinda.kurande@gmail.com7722030521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026